Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MedWatch training course

This article was originally published in The Tan Sheet

Executive Summary

FDA has launched an online training seminar on MedWatch and patient safety aimed at health care professional students, practitioners and consumers, the agency announces Jan. 30. The course outlines the agency's role in post-marketing safety surveillance for medical products, describes the reporting to MedWatch, discusses how reports are used by FDA and identifies ways MedWatch disseminates safety information about medical products, FDA states. As part of the recently enacted Dietary Supplement and Nonprescription Drug Consumer Protection Act, adverse events for supplements and monographed OTCs must be submitted using the MedWatch form (1"The Tan Sheet," Dec. 18, 2006, p. 4)...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS100188

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel